Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Oncology

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

Keratoses Clinical Trials

A listing of Keratoses medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (22) clinical trials

Clinical Trials of Texas, Inc. is conducting a research study of an investigational topical medication for dry, scaly skin caused by the sun (Actinic Keratosis.) Qualified participants receive study-related medical care from a board-certified dermatologist, study exams, evaluations and investigational medication. Eligibility Criteria: You may be eligible if you: • ...

Phase N/A

A research study is evaluating an investigational topical medication for actinic keratosis (AK) lesions of the face or scalp. This research study may be an option if you: • Have 4-8 actinic keratosis lesions on the face or scalp • Do not have any atypical or rapidly changing AK lesions ...

Phase N/A

Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis

It is an open-label, multiple-dose, pharmacokinetic study. In stage 1, plasma concentration of solamargine will be examined after the test products were administrated to 5 subjects with Actinic Keratosis (AK). Thereafter, an interim report based on the results of stage 1 will be submitted for Taiwan Center for Drug Evaluation ...


Actinic Keratoses Treatment With Metvix in Combination With Light

The main objective of this study is to compare efficacy and safety of Metvix® natural daylight photodynamic therapy with those of Metvix® conventional photodynamic therapy in subjects with mild actinic keratoses (intra-individual comparison)


Using a Cold Atmospheric Plasma Device to Treat Skin Disorders

This study examines the efficacy of a non-thermal, atmospheric plasma device in the treatment of a number of different skin disorders

Phase N/A

Protocols for Painless Photodynamic Therapy (PDT) of Actinic Keratoses

This study is being done to compare two modified versions of the standard ALA-PDT (Aminolevulinate-Photodynamic Therapy) treatment of actinic keratoses. The treatment has been modified in one of two ways, either: (#1) a shortened incubation time (1 hr), or (#2) light exposure that begins immediately after application of the Levulan. ...


Tobacco Cessation Intervention Study for Oral Diseases

It has been concluded that available evidence suggests that behavioral interventions for tobacco cessation conducted by oral health professionals incorporating an oral examination component in the dental office or community setting may increase tobacco abstinence rates among both cigarette smokers and smokeless tobacco users (Cochrane Database Syst Rev.6:CD005084.) However, efficacy ...

Phase N/A

Ingenol Mebutate Gel 0.05% in Kidney Transplant Recipients With Actinic Keratoses

Ingenol mebutate gel, 0.05%, commercially supplied in a box of 2 single use, unit dose tubes for topical application for each 25cm2, four conjunctive 25cm2 areas (100cm2) will be treated. If the 100 cm2 area is not cleared at Day 57 (+/- 3 Days), a second treatment cycle will be ...


Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field Cancerization

Twenty patients with multiple thin actinic keratosis (AK) on the face will be included in the study. They will be informed of the procedure in detail and sign a consent form. Digital photographs will be done in a standardized way. Prior to treatment, all patients will undergo 2 skin biopsies ...

Phase N/A

Validation of SHADE a Mobile Technology for Monitoring of Ultraviolet Exposure

The incidence of non-melanoma skin cancers, due to increased ultraviolet (UV) exposure, has increased by 300% over the past 2 decades. The innovative UV sensor, Shade, is designed to help people manage their UV exposure by quantifying their UV exposure levels through a linked smartphone application. In order to validate ...

Phase N/A